Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
CANCvsWDNAETF Comparison
Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. WisdomTree BioRevolution Fund (WDNA) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.45% for WDNA. CANC is up 3.55% year-to-date (YTD) with +$43M in YTD flows. WDNA performs worse with 1.25% YTD performance, and -$357K in YTD flows. Run a side-by-side ETF comparison of CANC and WDNA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs WDNA performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC WDNA | -1.54%-3.53% | +2.94%+1.22% | +3.55%+1.25% | +44.18%+34.84% | n/a+8.51% | n/an/a |
| Flows | CANC WDNA | +$14M- | +$51M-$357K | +$43M-$357K | +$65M-$357K | --$524K | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC WDNA | +23.29%+23.55% | +25.12%+28.66% | n/a+24.59% | n/an/a |
| Max drawdown | CANC WDNA | -5.18%-9.63% | -17.26%-17.47% | n/a-37.80% | n/an/a |
| Max drawdown duration | CANC WDNA | 17d50d | 80d106d | n/a901d | n/an/a |
CANC | WDNA | |
Last sale 3/13/2026 at 1:30 PM | $35.99 | $17.08 |
| Previous close 03/12/2026 | $36.33 | $17.25 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
CANC | WDNA | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
CANC | WDNA | |
|---|---|---|
| Last price | $35.99 | $17.08 |
| 1D performance | -0.95% | -1.00% |
| AuM | $162.12 M | $2.23 M |
| E/R | 0.99% | 0.45% |
CANC | WDNA | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Tema | WisdomTree |
| Benchmark | - | WisdomTree BioRevolution Index |
| N° of holdings | 46 | 75 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 15, 2023 | June 3, 2021 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the CANC and WDNA ETFs performed in 2026?
As of March 13, 2026, CANC is up 3.55% year-to-date (YTD), while WDNA has returned 1.25%. That puts CANC better performer ahead so far this year.
Which ETF is attracting more investor money: CANC or WDNA?
Year-to-date, the CANC ETF saw +$43M in flows, compared to -$357K for WDNA.
Which ETF is more volatile: CANC or WDNA?
Over the past year, CANC had a volatility of 25.12%, while WDNA experienced 28.66%.
Which ETF is bigger: CANC or WDNA?
As of March 13, 2026, CANC holds $162.12 M in assets under management (AUM), while WDNA manages $2.23 M.
What sectors do the CANC and WDNA ETFs invest in?
CANC leans toward sectors like Health Care. Meanwhile, WDNA focuses on Health Care.
What are the top holdings of the CANC ETF and WDNA ETF?
CANC top holdings include REVOLUTION MEDICINES INC, BRIDGEBIO PHARMA and NOVARTIS. WDNA holds in its top three: US86366E1064, MODERNA INC and NATERA.
Which ETF is more diversified: CANC or WDNA?
CANC holds 56 securities with 56.2% of its assets in the top 15. WDNA has 85 securities and a top 15 weight of 37.91%.
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
